APTALIS PHARMATECH INC | AbbVie | Ohio | state | 2013 | $25,390 | | training reimbursement |
BAUSH & LOMB | Bausch Health | South Carolina | state | 2010 | $615,965 | | training reimbursement |
ST. JUDE MEDICAL | Abbott Laboratories | South Carolina | state | 2009 | $59,305 | | training reimbursement |
Genzyme Corporation | Sanofi | New Mexico | state | 2008 | $277,372 | | training reimbursement |
ABBOTT MEDICAL OPTICS INC. | Abbott Laboratories | California | state | 2013 | $73,582 | | training reimbursement |
MYLAN TECHNOLOGIES | Viatris | Vermont | state | 2014 | $206,180 | | training reimbursement |
General Nutrition Corporation | Harbin Pharmaceutical Group | Indiana | state | 2014 | $200,000 | | training reimbursement |
Amneal Pharmaceuticals, LLC | Amneal Pharmaceuticals | Kentucky | state | 2014 | $25,000 | | training reimbursement |
C3I | Merck | New Hampshire | state | 2014 | $9,576 | | training reimbursement |
EMD Millipore | Merck KGaA (EMD) | New Hampshire | state | 2015 | $53,263 | | training reimbursement |
C3I | Merck | New Hampshire | state | 2015 | $5,908 | | training reimbursement |
PHARMAVITE LLC | Otsuka Pharmaceutical | California | state | 2014 | $17,618 | | training reimbursement |
BOEHRINGER INGELHEIM FREMONT, INC. | Boehringer Ingelheim | California | state | 2014 | $248,794 | | training reimbursement |
ABBOTT VASCULAR, INC. | Abbott Laboratories | California | state | 2014 | $344,534 | | training reimbursement |
ALLERGAN INC | AbbVie | California | state | 2015 | $325,700 | | training reimbursement |
AMGEN INC | Amgen | California | state | 2015 | $198,301 | | training reimbursement |
GILEAD SCIENCES INC | Gilead Sciences | California | state | 2015 | $191,250 | | training reimbursement |
Abbott Vascular Inc | Abbott Laboratories | California | state | 2016 | $1,201,228 | | training reimbursement |
Hospira Inc. | Pfizer | Colorado | state | 2014 | $31,104 | | training reimbursement |
AstraZeneca Pharmaceuticals | AstraZeneca | Delaware | state | 2016 | $5,868 | | training reimbursement |
Intervet, Inc. | Merck | Delaware | state | 2013 | $16,236 | | training reimbursement |
Intervet, Inc. | Merck | Delaware | state | 2015 | $29,352 | | training reimbursement |
Intervet, Inc. | Merck | Delaware | state | 2016 | $28,919 | | training reimbursement |
BioLife Plasma Services L.P. | Takeda Pharmaceutical | Idaho | state | 2011 | $523,620 | | training reimbursement |
Merck (2015) | Merck | Virginia | state | 2016 | $450,000 | | training reimbursement |
Abbott Laboratories | Abbott Laboratories | Arizona | state | 2016 | $240,000 | | training reimbursement |
AstraZeneca Pharmaceuticals LP | AstraZeneca | Indiana | state | 2017 | $200,000 | | training reimbursement |
BOEHRINGER INGELHEIM FREMONT INC | Boehringer Ingelheim | California | state | 2017 | $249,388 | | training reimbursement |
AMGEN INC | Amgen | California | state | 2018 | $198,000 | | training reimbursement |
AVANIR PHARMACEUTICALS INC | Otsuka Pharmaceutical | California | state | 2017 | $12,225 | | training reimbursement |
KITE PHARMA INC | Gilead Sciences | California | state | 2018 | $10,148 | | training reimbursement |
Supernus Pharmaceuticals, Inc. | Supernus Pharmaceuticals | Maryland | state | 2018 | $44,733 | | training reimbursement |
Merck (2015) | Merck | Virginia | state | 2017 | $450,000 | | training reimbursement |
Abbott Laboratories Retrain | Abbott Laboratories | Virginia | state | 2017 | $65,639 | | training reimbursement |
Abbott Laboratories. | Abbott Laboratories | Virginia | state | 2017 | $34,078 | | training reimbursement |
BOEHRINGER INGELHEIM FREMONT INC | Boehringer Ingelheim | California | state | 2019 | $343,449 | | training reimbursement |
VERTEX PHARMACEUTICALS (SAN DIEGO) LLC | Vertex Pharmaceuticals | California | state | 2019 | $16,570 | | training reimbursement |
Novartis Gene Therapies, Inc. (formerly AveXi | Novartis | Colorado | state | 2020 | $95,736 | | training reimbursement |
Novartis Gene Therapies, Inc. (formerly AveXi | Novartis | Colorado | state | 2021 | $77,030 | | training reimbursement |
Novartis Gene Therapies, Inc. (formerly AveXi | Novartis | Colorado | state | 2021 | $19,850 | | training reimbursement |
Novartis Gene Therapies, Inc. (formerly AveXi | Novartis | Colorado | state | 2021 | $23,110 | | training reimbursement |
Cambrex Charles City, Inc. | Cambrex | Iowa | state | 2020 | $458,408 | | training reimbursement |
Cambrex Charles City, Inc. | Cambrex | Iowa | state | 2017 | $502,233 | | training reimbursement |
Elanco Us Inc. | Elanco Animal Health | Iowa | state | 2015 | $684,174 | | training reimbursement |
Cambrex Charles City, Inc. | Cambrex | Iowa | state | 2014 | $740,512 | | training reimbursement |
Newlink Genetics Corporation | Lumos Pharma | Iowa | state | 2014 | $200,071 | | training reimbursement |
Cambrex Charles City, Inc. | Cambrex | Iowa | state | 2013 | $318,203 | | training reimbursement |
Intervet Inc. | Merck | Kansas | state | 2021 | $1,000 | | training reimbursement |
Eli Lilly and Company | Eli Lilly | North Carolina | state | 2022 | $14,958 | | training reimbursement |
Merck Manufacturing (project 6) | Merck | North Carolina | state | 2022 | $167,242 | | training reimbursement |
Novartis Gene Therapies (frmly AveXis, Inc.) | Novartis | North Carolina | state | 2022 | $5,798 | | training reimbursement |
Pfizer (project 2) | Pfizer | North Carolina | state | 2022 | $153,219 | | training reimbursement |
Pfizer, Inc. (Chapel Hill) | Pfizer | North Carolina | state | 2022 | $20,984 | | training reimbursement |
Abbott Vascular Inc | Abbott Laboratories | California | state | 2021 | $603,200 | | training reimbursement |
Boehringer Ingelheim Fremont Inc | Boehringer Ingelheim | California | state | 2021 | $898,743 | | training reimbursement |
Genentech USA Inc | Roche | California | state | 2021 | $68,185 | | training reimbursement |
Abbott Vascular Inc | Abbott Laboratories | California | state | 2022 | $198,000 | | training reimbursement |
Baxalta Us Inc | Takeda Pharmaceutical | California | state | 2022 | $20,998 | | training reimbursement |
PBM Nutritionals | Perrigo | Vermont | state | 2012 | $144,711 | | training reimbursement |
Novartis Pharmaceuticals Corp. & Affiliates | Novartis | Nebraska | state | 2020 | $221,667 | | tax rebate |
Novozymes Blair, Inc. | Novo Holdings A/S | Nebraska | state | 2020 | $1,368,830 | | tax rebate |
Zoetis, LLC | Zoetis | Nebraska | state | 2022 | $789,317 | | tax rebate |
Novozymes Blair, Inc. | Novo Holdings A/S | Nebraska | state | 2023 | $475,775 | | tax rebate |
Aventis Pharmaceuticals | Sanofi | Missouri | local | 2007 | $338,637 | | tax increment financing |
Aventis Pharmaceuticals | Sanofi | Missouri | local | 2008 | $2,507,992 | | tax increment financing |
Aventis Pharmaceuticals | Sanofi | Missouri | local | 2010 | $2,288,978 | | tax increment financing |
Aventis Pharmaceuticals | Sanofi | Missouri | local | 2011 | $2,224,018 | | tax increment financing |
Aldrich Chemical | Merck KGaA (EMD) | Wisconsin | state | 2003 | $2,426,984 | | tax increment financing |
Emergent Biosolutions | Emergent BioSolutions | Michigan | state | 2012 | $2,821,980 | | tax increment financing |
Emergent Biosolutions | Emergent BioSolutions | Michigan | state | 2012 | $1,796,389 | | tax increment financing |
Aventis Pharmaceuticals | Sanofi | Missouri | local | 2012 | $2,352,115 | | tax increment financing |
Aventis Pharmaceuticals | Sanofi | Missouri | local | 2015 | $1,375,894 | | tax increment financing |
Vertex Pharmaceuticals | Vertex Pharmaceuticals | Massachusetts | local | 2015 | $9,000,000 | | tax increment financing |
ACTAVIS ELIZABETH LLC | Teva Pharmaceutical Industries | New Jersey | state | | undisclosed | | tax credit/rebate; property tax abatement |
AMNEAL PHARMACEUTICALS LLC | Amneal Pharmaceuticals | New Jersey | state | | undisclosed | | tax credit/rebate; property tax abatement |
FOREST LABORATORIES, INC. | AbbVie | New Jersey | state | | undisclosed | | tax credit/rebate; property tax abatement |
FOREST RESEARCH INSTITUTE, INC. | AbbVie | New Jersey | state | | undisclosed | | tax credit/rebate; property tax abatement |
Doral/Pfizer | Pfizer | New York | local | 2003 | $613,020 | | tax credit/rebate; property tax abatement |
Bristol Myers Squibb (Mr. Leon Squibb) | Bristol-Myers Squibb | New York | local | 2003 | $343,428 | | tax credit/rebate; property tax abatement |
Bausch & Lomb | Bausch Health | New York | local | 2003 | $266,156 | | tax credit/rebate; property tax abatement |
Johnson & Johnson | Johnson & Johnson | New York | local | 2003 | $167,430 | | tax credit/rebate; property tax abatement |
Luitpold Pharmaceuticals | Daiichi Sankyo | New York | local | 2003 | $61,743 | | tax credit/rebate; property tax abatement |
Regeneron II(Mill Road) | Regeneron Pharmaceuticals | New York | local | 2003 | $46,350 | | tax credit/rebate; property tax abatement |
Luitpold Pharmaceuticals | Daiichi Sankyo | New York | local | 2003 | $31,580 | | tax credit/rebate; property tax abatement |
Valmed Pharamaceutical, Inc. | AbbVie | New York | local | 2003 | $4,607 | | tax credit/rebate; property tax abatement |
Doral Arrowwood (Pfizer) | Pfizer | New York | local | 2004 | $3,137,110 | | tax credit/rebate; property tax abatement |
Pfizer, Inc. | Pfizer | New York | local | 2004 | $1,919,713 | | tax credit/rebate; property tax abatement |
Bristol Myers Squibb (Mr. Leon Squibb) | Bristol-Myers Squibb | New York | local | 2004 | $355,511 | | tax credit/rebate; property tax abatement |
Bausch & Lomb | Bausch Health | New York | local | 2004 | $214,683 | | tax credit/rebate; property tax abatement |
Purdue Pharma LP | Purdue Pharma | New York | local | 2004 | $180,174 | | tax credit/rebate; property tax abatement |
Johnson & Johnson | Johnson & Johnson | New York | local | 2004 | $146,695 | | tax credit/rebate; property tax abatement |
American Pharmaceutical Partners, Inc. | Bristol-Myers Squibb | New York | local | 2004 | $85,934 | | tax credit/rebate; property tax abatement |
Luitpold Pharmaceuticals | Daiichi Sankyo | New York | local | 2004 | $68,264 | | tax credit/rebate; property tax abatement |
Luitpold Pharmaceuticals | Daiichi Sankyo | New York | local | 2004 | $34,916 | | tax credit/rebate; property tax abatement |
Valmed Parmaceuticals, Inc. | AbbVie | New York | local | 2004 | $30,430 | | tax credit/rebate; property tax abatement |
Purdue Pharma LP | Purdue Pharma | New York | local | 2004 | $23,560 | | tax credit/rebate; property tax abatement |
Valmed Pharamaceutical, Inc. | AbbVie | New York | local | 2004 | $4,364 | | tax credit/rebate; property tax abatement |
Pfizer, Inc. | Pfizer | New York | local | 2005 | $3,276,473 | | tax credit/rebate; property tax abatement |
OSI Pharmaceuticals, Inc. | Astellas Pharma | New York | local | 2005 | $1,079,994 | | tax credit/rebate; property tax abatement |
Doral Arrowwood (Pfizer) | Pfizer | New York | local | 2005 | $701,075 | | tax credit/rebate; property tax abatement |
American Pharmaceutical Partners, Inc. | Bristol-Myers Squibb | New York | local | 2005 | $495,039 | | tax credit/rebate; property tax abatement |